NDC 82009-160-11
USTEKINUMAB-TTWE 45 mg/.5mL
ustekinumab-ttwe · INJECTION, SOLUTION
USTEKINUMAB-TTWE is a injection, solution containing ustekinumab-ttwe at a strength of 45 mg/.5mL. Manufactured by Quallent Pharmaceuticals Health LLC.
Key Facts
- Brand Name
- USTEKINUMAB-TTWE
- Generic Name
- ustekinumab-ttwe
- NDC Code (Package)
82009-160-11- NDC Code (Product)
82009-160- Manufacturer
- Quallent Pharmaceuticals Health LLC
- Strength
- 45 mg/.5mL
- Dosage Form
- INJECTION, SOLUTION
- Route
- SUBCUTANEOUS
- Marketing Status
- Application #
- BLA761373
- Drug Class
- Interleukin-12 Antagonist [EPC]; Interleukin-23 Antagonist [EPC]
- Marketing Start
- 04/15/2025
Recall History
No Recall HistoryView Full Drug Page
USTEKINUMAB-TTWE — All PackagesNot medical advice. This information is for reference only. Always consult your doctor or pharmacist.